Anti-CHD2 monoclonal antibody Made to order

Background: Neurodevelopmental disorders include a broad spectrum of conditions, which are characterized by delayed motor and/or cognitive milestones and by a variable range of intellectual disability with or without an autistic behavior. Several genetic factors have been implicated in intellectual disability onset and exome sequencing studies have recently identified new inherited or de novo mutations in patients with neurodevelopmental disorders. Case: We report the case of two monozygotic twins who came for the first time to our attention at the age of 20 months for a global neurodevelopmental delay associated with an autism spectrum disorder, hypotonia, postnatal microcephaly, stereotypic movements and circadian rhythm alterations in association with late-onset epilepsy. MECP2 sequence was normal. A CGH-array analysis revealed in both twins two maternally inherited duplications on chromosomes 8p22 and 16p13.11. The latter has been previously associated with neurodevelopmental disorders. We performed an exome sequencing analysis on one twin and her parents and identified a CHD2 mutation, previously described in association with a phenotypic spectrum overlapping our patients' phenotype. Conclusions: This work underlines the importance to consider a CHD2 involvement in children with intellectual disability and autism spectrum disorder even in the absence of epilepsy at an early age. It also highlights the necessity to re-evaluate inherited copy number variants with low penetrance and/or high phenotypic variability because an underlying de novo molecular event can be the major cause of the phenotype. This is essential in order to reach a correct diagnosis and provide the couple with a proper recurrence risk. (c) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

In NMR spectra of partially deuterated proteins methyl correlations are commonly observed as a combination of signals from (CH3)-C-13, (CH2D)-C-13 and (CHD2)-C-13 isotopomers. In a number of NMR applications, methyl groups of the (CHD2)-C-13 variety are targeted because of their AX-like character and concomitant simplification of the involved relaxation mechanisms. Although complete elimination of signals from (CH2D)-C-13 methyl groups can be easily achieved in such applications, if the magnetization is not transferred through deuterium nuclei, efficient suppression of usually stronger (CH3)-C-13 peaks is more problematic. A pair of simple pulse-scheme elements are presented that achieve almost complete suppression of (CH3)-C-13 signals in the mixtures of (CH3)-C-13/(CH2D)-C-13/(CHD2)-C-13 methyl isotopomers of small proteins at the expense of a moderate (similar to 20-to-40%) reduction in intensities of the targeted (CHD2)-C-13 groups. The approaches described are based purely on scalar coupling ((1)J(CH)) evolution properties of different C-13 and H-1 transitions within (CH3)-C-13 spin-systems and are superior to magnetization transfer through deuterons with respect to sensitivity of the detected (CHD2)-C-13 methyl signals. (C) 2011 Elsevier Inc. All rights reserved.